Trusted by researchers at leading institutions
Fred Hutchinson Cancer Center University of Pennsylvania (UPenn) MIT UCSF University of Michigan (U-M) Boston University (BU) UT MD Anderson Cancer Center Fred Hutchinson Cancer Center University of Pennsylvania (UPenn) MIT UCSF University of Michigan (U-M) Boston University (BU) UT MD Anderson Cancer Center Fred Hutchinson Cancer Center University of Pennsylvania (UPenn) MIT UCSF University of Michigan (U-M) Boston University (BU) UT MD Anderson Cancer Center Fred Hutchinson Cancer Center University of Pennsylvania (UPenn) MIT UCSF University of Michigan (U-M) Boston University (BU) UT MD Anderson Cancer Center

Research use only

HiTE™ Transduction Enhancer

Lentiviral transduction enhancer for primary T cells, NK cells, and stem cells. Add it to the vector mix.

Cell Type

(+) CD34+ HSPCs, MSCs, ESCs, Macrophages, Fibroblasts &

If your cell type isn’t listed here, reach out to us and we’ll direct you to the right product.

Size

$99

1 mg trial · ~20 reactions

Quantity

Trial kits are excluded from the 10% promo.

Available through Fisher Scientific. For GMP grade inquiries, contact us.

Description

HiTE™ is a synthetic peptide supplied as three formulations: HiTE-T, HiTE-NK, and HiTE-SC. It is added directly to a lentiviral transduction.

  • No plate coating.
  • No spinoculation.
  • Fits a standard transduction protocol.
  • Shipped on dry ice. Store at −80°C.

For research use only. Not for use in diagnostic procedures. HiTE™ is a trademark of PyrOjas Corporation.

Your Cart

Added to cart!

Purchase Order

Purchase Order Details
Billing Contact
Shipping Address

Order Summary

Subtotal $0
Total $0
Authorization
Your signature will appear here

Generate Quote

Institution Details
Contact Information
Shipping Address

Order Summary

Subtotal $0
Total $0